Flowonix
PrivateLast Round
Series B
Jan 4, 2021
Total Funding Raised
$75M
Company Overview
Flowonix is a medical technology company that develops implantable therapeutic devices designed to facilitate drug infusion and delivery for the management of chronic pain and neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flowonix Comps
Public and private peers based on sector, stage, and business model.
Flowonix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 4, 2021 | ||||
| Debt | Dec 23, 2020 | ||||
| Series B | Sep 19, 2018 | ||||
| VC Round | Jun 1, 2016 | ||||
| Debt | Nov 11, 2014 | ||||
VC Round | May 23, 2012 |
Flowonix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OmniCapital Group | VC Round |
| Hercules Capital | VC Round, Debt |
| Farallon Capital Management | Series B |
| Elevage Capital | Debt |
| SWK Holdings Corporation | Debt |
| Yaho Poker | VC Round |
| Clarus Ventures | Debt |
Flowonix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Flowonix's valuation, stock price, and market status.